This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Bankruptcy

May 28, 2010

Pharma Co. Buys Bankrupt Biotech

San Diego-based Phage Pharmaceuticals Inc. and parent company, New Technologies Holding Pte. Ltd. of Singapore, acquired substantially all the assets of Phage Biotechnology Corp. out of Chapter 11 bankruptcy.

By Mandy Jackson

Daily Journal Staff Writer

San Diego-based Phage Pharmaceuticals Inc. and parent company, New Technologies Holding Pte. Ltd. of Singapore, acquired substantially all the assets of Phage Biotechnology Corp. out of Chapter 11 bankruptcy. The transaction value was not disclosed.

From Troutman Sanders LLP, Melvin Weinberg in New York and Fletcher W. Paddison in San Diego counseled Phage Pharmaceuticals. Marc Winth...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up